| __timestamp | Regeneron Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2819557000 | 4320000 |
| Thursday, January 1, 2015 | 4103728000 | 2538000 |
| Friday, January 1, 2016 | 4860427000 | 3337000 |
| Sunday, January 1, 2017 | 5872227000 | 4003000 |
| Monday, January 1, 2018 | 6710800000 | 8386000 |
| Tuesday, January 1, 2019 | 7863400000 | 4461000 |
| Wednesday, January 1, 2020 | 8497100000 | 1050000 |
| Friday, January 1, 2021 | 16071700000 | 2963000 |
| Saturday, January 1, 2022 | 12172900000 | 1772000 |
| Sunday, January 1, 2023 | 13117200000 | 314000 |
| Monday, January 1, 2024 | 14202000000 |
Cracking the code
In the dynamic world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Regeneron Pharmaceuticals, Inc. has demonstrated a remarkable trajectory, with its revenue surging by over 360% from 2014 to 2023. This growth is highlighted by a peak in 2021, where revenues reached approximately $16 billion, showcasing Regeneron's robust market presence and innovative prowess.
In stark contrast, Viridian Therapeutics, Inc. has faced a more challenging path. Despite a promising start in 2018, with revenues peaking at around $8 million, the company has seen a significant decline, with 2023 revenues plummeting to just $314,000. This stark disparity underscores the competitive and volatile nature of the biotech industry, where strategic decisions and market dynamics can lead to vastly different outcomes for companies operating within the same sector.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Examining Key Revenue Metrics
AbbVie Inc. vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Annual Revenue Comparison: PTC Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Annual Revenue Comparison: Perrigo Company plc vs Viridian Therapeutics, Inc.
Revenue Showdown: Dynavax Technologies Corporation vs Viridian Therapeutics, Inc.
Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Xencor, Inc. vs Viridian Therapeutics, Inc.: Annual Revenue Growth Compared